CCL2 regulated by the CTBP1-AS2/miR-335-5p axis promotes hemangioma progression and angiogenesis

References

• Jia J, Huang X, Zhang WF, et al. Human monocyte-derived hemangioma-like endothelial cells: evidence from an in vitro study. Cardiovasc Pathol. 2008;17(4):212–218. doi: 10.1016/j.carpath.2007.09.003.
   PubMed Web of Science ®Google Scholar
• Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet. 2017;390(10089):85–94. doi: 10.1016/S0140-6736(16)00645-0.
   PubMed Web of Science ®Google Scholar
• Jain S, Singaraju S, Singaraju M. Central hemangioma: a case report and review of literature. J Indian Soc Pedod Prev Dent. 2016;34(1):87–91. doi: 10.4103/0970-4388.175525.
   PubMedGoogle Scholar
• Vilgelm AE, Richmond A. Chemokines modulate immune surveillance in tumorigenesis, metastasis, and response to immunotherapy. Front Immunol. 2019;10:333. doi: 10.3389/fimmu.2019.00333.
   PubMed Web of Science ®Google Scholar
• Deshmane SL, Kremlev S, Amini S, et al. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009;29(6):313–326. doi: 10.1089/jir.2008.0027.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yan Y, Cui X, et al. CCL2 expression correlates with snail expression and affects the prognosis of patients with gastric cancer. Pathol Res Pract. 2017;213(3):217–221. doi: 10.1016/j.prp.2016.12.013.
   PubMed Web of Science ®Google Scholar
• D’Arcangelo D, Nicodemi EM, Rossi S, et al. Identification of serum regression signs in infantile hemangioma. PLoS One. 2014;9(3):e88545. doi: 10.1371/journal.pone.0088545.
   PubMed Web of Science ®Google Scholar
• Tutar Y. miRNA and cancer; computational and experimental approaches. Curr Pharm Biotechnol. 2014;15(5):429–429. doi: 10.2174/138920101505140828161335.
   PubMed Web of Science ®Google Scholar
• Sun Y, Zheng Y, Wang C, et al. Glutathione depletion induces ferroptosis, autophagy, and premature cell senescence in retinal pigment epithelial cells. Cell Death Dis. 2018;9(7):753. doi: 10.1038/s41419-018-0794-4.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233. doi: 10.1016/j.cell.2009.01.002.
   PubMed Web of Science ®Google Scholar
• Nakashima T, Jinnin M, Etoh T, et al. Down-regulation of mir-424 contributes to the abnormal angiogenesis via MEK1 and cyclin E1 in senile hemangioma: its implications to therapy. PLoS One. 2010;5(12):e14334. doi: 10.1371/journal.pone.0014334.
   PubMed Web of Science ®Google Scholar
• Jathar S, Kumar V, Srivastava J, et al. Technological developments in lncRNA biology. Adv Exp Med Biol. 2017;1008:283–323.
   PubMed Web of Science ®Google Scholar
• Chen LL. Linking long noncoding RNA localization and function. Trends Biochem Sci. 2016;41(9):761–772. doi: 10.1016/j.tibs.2016.07.003.
   PubMed Web of Science ®Google Scholar
• Li MM, Dong CX, Sun B, et al. LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3/NF-κB pathway. Life Sci. 2019;239:116946. doi: 10.1016/j.lfs.2019.116946.
   PubMed Web of Science ®Google Scholar
• Dai Y, Wan Y, Qiu M, et al. lncRNA MEG3 suppresses the tumorigenesis of hemangioma by sponging miR-494 and regulating PTEN/PI3K/AKT pathway. Cell Physiol Biochem. 2018;51(6):2872–2886. doi: 10.1159/000496040.
   PubMedGoogle Scholar
• Li X, Chen B, Chi D, et al. lncRNA CASC9 regulates cell migration and invasion in hemangioma endothelial cells by targeting miR-125a-3p/Nrg1. Onco Targets Ther. 2019;12:423–432. doi: 10.2147/OTT.S181914.
   PubMed Web of Science ®Google Scholar
• Cui K, Zhu G. LncRNA CTBP1-AS2 regulates miR-216a/PTEN to suppress ovarian cancer cell proliferation. J Ovarian Res. 2020;13(1):84. doi: 10.1186/s13048-020-00689-6.
   PubMed Web of Science ®Google Scholar
• Liu LX, Liu B, Yu J, et al. SP1-induced upregulation of lncRNA CTBP1-AS2 accelerates the hepatocellular carcinoma tumorigenesis through targeting CEP55 via sponging miR-195-5p. Biochem Biophys Res Commun. 2020;533(4):779–785. doi: 10.1016/j.bbrc.2020.09.080.
   PubMed Web of Science ®Google Scholar
• Zhao W, Geng D, Li S, et al. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer Med. 2018;7(3):842–855. doi: 10.1002/cam4.1353.
   PubMed Web of Science ®Google Scholar
• Zhu X, Guo Y, Yao S, et al. Synergy between kaposi’s sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway. Oncogene. 2014;33(15):1986–1996. doi: 10.1038/onc.2013.136.
   PubMed Web of Science ®Google Scholar
• Stamatovic SM, Keep RF, Mostarica-Stojkovic M, et al. CCL2 regulates angiogenesis via activation of ets-1 transcription factor. J Immunol. 2006;177(4):2651–2661. doi: 10.4049/jimmunol.177.4.2651.
   PubMed Web of Science ®Google Scholar
• Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344–352. doi: 10.1038/nature12986.
   PubMed Web of Science ®Google Scholar
• Legler DF, Thelen M. Chemokines: chemistry, biochemistry and biological function. Chimia (Aarau). 2016;70(12):856–859. doi: 10.2533/chimia.2016.856.
   PubMed Web of Science ®Google Scholar
• Lim SY, Yuzhalin AE, Gordon-Weeks AN, et al. Targeting the CCL2-CCR2 signaling axis in cancer metastasis. Oncotarget. 2016;7(19):28697–28710. doi: 10.18632/oncotarget.7376.
   PubMedGoogle Scholar
• Yasui H, Kajiyama H, Tamauchi S, et al. CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway. Clin Exp Metastasis. 2020;37(1):145–158. doi: 10.1007/s10585-019-09993-y.
   PubMed Web of Science ®Google Scholar
• Bonapace L, Coissieux MM, Wyckoff J, et al. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. Nature. 2014;515(7525):130–133. doi: 10.1038/nature13862.
   PubMed Web of Science ®Google Scholar
• Isik FF, Rand RP, Gruss JS, et al. Monocyte chemoattractant protein-1 mRNA expression in hemangiomas and vascular malformations. J Surg Res. 1996;61(1):71–76. doi: 10.1006/jsre.1996.0083.
   PubMed Web of Science ®Google Scholar
• Tiwari A, Mukherjee B, Dixit M. MicroRNA key to angiogenesis regulation: miRNA biology and therapy. Curr Cancer Drug Targets. 2018;18(3):266–277. doi: 10.2174/1568009617666170630142725.
   PubMed Web of Science ®Google Scholar
• Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79(1):351–379. doi: 10.1146/annurev-biochem-060308-103103.
   PubMed Web of Science ®Google Scholar
• Wang W, Shen F, Wang C, et al. MiR-1-3p inhibits the proliferation and invasion of bladder cancer cells by suppressing CCL2 expression. Tumour Biol. 2017;39(6):1010428317698383. doi: 10.1177/1010428317698383.
   Google Scholar
• Liu D, Zhang XL, Yan CH, et al. MicroRNA-495 regulates the proliferation and apoptosis of human umbilical vein endothelial cells by targeting chemokine CCL2. Thromb Res. 2015;135(1):146–154. doi: 10.1016/j.thromres.2014.10.027.
   PubMed Web of Science ®Google Scholar
• Luo L, Xia L, Zha B, et al. miR-335-5p targeting ICAM-1 inhibits invasion and metastasis of thyroid cancer cells. Biomed Pharmacother. 2018;106:983–990. doi: 10.1016/j.biopha.2018.07.046.
   PubMed Web of Science ®Google Scholar
• Du W, Tang H, Lei Z, et al. miR-335-5p inhibits TGF-β1-induced epithelial-mesenchymal transition in non-small cell lung cancer via ROCK1. Respir Res. 2019;20(1):225. doi: 10.1186/s12931-019-1184-x.
   PubMed Web of Science ®Google Scholar
• Wang K, Jin W, Song Y, et al. LncRNA RP11-436H11.5, functioning as a competitive endogenous RNA, upregulates BCL-W expression by sponging miR-335-5p and promotes proliferation and invasion in renal cell carcinoma. Mol Cancer. 2017;16(1):166. doi: 10.1186/s12943-017-0735-3.
   PubMedGoogle Scholar
• Li P, Li Y, Dai Y, et al. The LncRNA H19/miR-1-3p/CCL2 axis modulates lipopolysaccharide (LPS) stimulation-induced normal human astrocyte proliferation and activation. Cytokine. 2020;131:155106. doi: 10.1016/j.cyto.2020.155106.
   PubMed Web of Science ®Google Scholar
• Shengnan J, Dafei X, Hua J, et al. Long non-coding RNA HOTAIR as a competitive endogenous RNA to sponge miR-206 to promote colorectal cancer progression by activating CCL2. J Cancer. 2020;11(15):4431–4441. doi: 10.7150/jca.42308.
   PubMed Web of Science ®Google Scholar
• Wang M, Zhao H. LncRNA CTBP1-AS2 promotes cell proliferation in hepatocellular carcinoma by regulating miR-623/cyclin D1 axis. Cancer Biother Radiopharm. 2020;35(10):765–770. doi: 10.1089/cbr.2019.3375.
   PubMed Web of Science ®Google Scholar
• He Z, Yang Y, Xing Z, et al. Intraperitoneal injection of IFN-γ restores microglial autophagy, promotes amyloid-β clearance and improves cognition in APP/PS1 mice. Cell Death Dis. 2020;11(6):440. doi: 10.1038/s41419-020-2644-4.
   PubMed Web of Science ®Google Scholar
• O’Connor T, Borsig L, Heikenwalder M. CCL2-CCR2 signaling in disease pathogenesis. Endocr Metab Immune Disord Drug Targets. 2015;15(2):105–118. doi: 10.2174/1871530315666150316120920.
   PubMed Web of Science ®Google Scholar